醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
AVTX · Avalo Therapeutics, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Avalo Therapeutics, Inc.（AVTX）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $2.0M；高管董事有效買入 —、有效賣出 $52K。最近申報 2026-09-18。
買入 Bought—
賣出 Sold$2.0M
有效買入 Effective bought—
有效賣出 Effective sold$52K
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-09-16 | Sullivan Christopher Ryan Chief Financial Officer | 賣出 Sell | 12,394 | $16.33 | $202K | SEC |
| 2026-09-10 | Sullivan Christopher Ryan Chief Financial Officer | 賣出 Sell | 10,185 | $17.62 | $179K | SEC |
| 2026-08-28 | Doyle Mittie Chief Medical Officer | 賣出 Sell | 679 | $20.00 | $14K | SEC |
| 2026-08-17 | Sullivan Christopher Ryan Chief Financial Officer | 賣出 Sell | 72,725 | $19.94 | $1.5M | SEC |
| 2026-08-17 | Doyle Mittie Chief Medical Officer | 賣出 Sell | 1,000 | $20.00 | $20K | SEC |
| 2026-08-10 | Doyle Mittie Chief Medical Officer | 賣出 Sell | 679 | $20.00 | $14K | SEC |
| 2026-08-11 | Riley Jennifer Chief Strategy Officer | 賣出 Sell · 有效 | 2,655 | $19.59 | $52K | SEC |
| 2026-07-27 | Doyle Mittie Chief Medical Officer | 賣出 Sell | 1,000 | $20.00 | $20K | SEC |
| 2026-06-30 | Doyle Mittie Chief Medical Officer | 賣出 Sell | 4,654 | $20.00 | $93K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-08-18 | Sullivan Christopher Ryan Officer | 31,031 | $622K | |
| 2026-08-17 | Sullivan Christopher Ryan Officer | 70,709 | $1.4M | 10b5-1 |
| 2026-08-17 | Doyle Mittie Officer | 5,037 | $99K | 10b5-1 |
| 2026-08-17 | Sullivan Christopher Ryan Officer | 3,749 | $75K | |
| 2026-08-11 | Riley Jennifer Officer | 2,655 | $52K | |
| 2026-08-10 | Doyle Mittie Officer | 679 | $12K | 10b5-1 |
內部人 Insiders
Sullivan Christopher Ryan、Doyle Mittie、Riley Jennifer